Aurora Cannabis (TSE:ACB) Trading Up 8.9% – Should You Buy?

Aurora Cannabis Inc. (TSE:ACB)’s share price was up 8.9% on Thursday . The company traded as high as C$8.65 and last traded at C$8.40. Approximately 678,771 shares were traded during mid-day trading, an increase of 15% from the average daily volume of 589,641 shares. The stock had previously closed at C$7.71.

Analyst Ratings Changes

Separately, ATB Capital decreased their price objective on Aurora Cannabis from C$9.00 to C$8.50 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. One analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Strong Buy” and a consensus price target of C$8.50.

Aurora Cannabis Trading Down 7.9%

The company has a debt-to-equity ratio of 18.72, a current ratio of 3.42 and a quick ratio of 2.48. The stock has a market cap of C$385.29 million, a P/E ratio of -6.72 and a beta of 1.11. The firm’s fifty day moving average price is C$6.70 and its two-hundred day moving average price is C$6.82.

Aurora Cannabis (TSE:ACB) last posted its quarterly earnings data on Wednesday, November 5th. The company reported C($0.91) earnings per share (EPS) for the quarter. The business had revenue of C$90.37 million for the quarter. Aurora Cannabis had a negative net margin of 22.55% and a negative return on equity of 8.36%. As a group, equities research analysts forecast that Aurora Cannabis Inc. will post -0.22 EPS for the current year.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.